Macquarie Group LTD Athenex, Inc. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.36 - $2.94 $1,725 - $3,730	-1,269 Reduced 1.78%	70,000 $95,000
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $390,974 - $1.41 Million	-95,827 Reduced 57.35%	71,269 $306,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $99,285 - $125,767	-8,977 Reduced 5.1%	167,096 $1.85 Million
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $1.79 Million - $2.54 Million	174,415 Added 10519.6%	176,073 $2.13 Million
Q2 2020 Aug 11, 2020	BUY	$7.11 - $13.76 $11,788 - $22,814	1,658 New	1,658 $23,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.